Search clinical trials for: budesonide and montelukast

Total 273126 results

Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable 5mg Tablet Under Fed Conditions

Healthy

India
Hull University Teaching Hospitals NHS Trust
Aerocrine AB

Completed

The Utility of feNO in the Differential Diagnosis of Chronic Cough (TUF)

Cough

United Kingdom
Bausch Health Americas, Inc.

Not yet recruiting

Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Ulcerative Colitis
University of New Mexico
American College of Clinical Pharmacy

Completed

Exercise Induced Bronchospasm in Children

Exercise Induced Bronchospasm

United States
Merck Sharp & Dohme LLC

Completed

MK0524 Asthma POC Study (0524-008)(COMPLETED)

Asthma
Aquilon Pharmaceuticals S.A.

Completed

Single-dose AQ001S PK Study in Healthy Volunteers (BORA)

Pharmacokinetics

Bulgaria
Salzburger Landeskliniken
University Hospital Heidelberg

Completed

Inhaled Budesonide and Acute Mountain Sickness

Acute Mountain Sickness

Austria
Qilu Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers

Healthy Volunteers

China
Kecioren Education and Training Hospital

Completed

Budesonide for Emergency Treatment of Acute Wheezing in Children

Asthma | Acute Asthma

Turkey
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable Tablets 5mg Under Fasted Conditions

Healthy

India
AstraZeneca

Completed

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

Asthma

United States, Puerto Rico
AstraZeneca

Completed

Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT

Asthma
AstraZeneca

Completed

Long-Term Safety of Symbicort in Asthmatic Children - SAPLING

Asthma
AstraZeneca

Completed

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg (CHASE 3)

Asthma

United States, Mexico, Slovakia, Panama
Wake Forest University

Completed

Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis

Atopic Dermatitis

United States
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler

Healthy

Finland
Bugra Kerget

Not yet recruiting

Effect of Montelukast Therapy on Clinical Course, Pulmonary Function, and Mortality in Patients With COVID-19

COVID-19 Pneumonia

Turkey
Istituto per la Ricerca e l'Innovazione Biomedica

Completed

Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis

Allergic Rhinitis

Italy
Tanta University

Completed

Three Treatment of Chronic Obstructive Pulmonary Disease Patients

COPD
Organon and Co

Completed

Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)

Asthma
CHA University
Merck Sharp & Dohme LLC

Completed

Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.

Mild Persistent Asthma
Hospital General de Requena
Esteve

Completed

Efficacy of Budesonide-Formoterol in Bronchiectasis

Bronchiectasis

Spain
Bahçeşehir University
The Scientific and Technological Research Council of Turkey; Medipol University

Recruiting

Investigation the Effect of Montelukast in COVID-19

COVID-19 | SARS-CoV-2

Turkey
Mitchell Grayson
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects

Nasal Allergy

United States
Kyowa Kirin Co., Ltd.

Completed

A Phase 4 Clinical Study of Brodalumab

Psoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic Erythroderma

Japan
University of Calgary
Ferring Pharmaceuticals

Not yet recruiting

Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis

Microscopic Colitis
NeoStrata Company, Inc.
Massachusetts General Hospital

Unknown

Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States
AstraZeneca

Completed

Titratable Dosing in Moderate to Severe Asthmatics

Asthma
Bausch Health Americas, Inc.
Cosmo Technologies Ltd

Completed

(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Ulcerative Colitis

Russian Federation, United Kingdom, Latvia, Poland, Estonia, Belgium, Australia, Lithuania, France, Sweden, Israel, Italy, Romania, Slovakia, Ukraine
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

A Study of 2 Doses of MAP0010 in Adult Asthmatics (P202)

Asthma

United States
Vanderbilt University Medical Center

Recruiting

Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

Intubation Complication

United States
Cynthia McEvoy
University of Florida; University of California, San Francisco; Thrasher Research... and other collaborators

Completed

Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial (SASSIE)

Bronchopulmonary Dysplasia (BPD)

United States
Dr. Falk Pharma GmbH

Completed

Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis

Proctitis

Germany
AstraZeneca

Completed

A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.

Asthma

United States
Ache Laboratorios Farmaceuticos S.A.

Completed

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma (Ach-ALN)

Asthma
Medical University of Lodz

Completed

Pharmacological Modulations of Allergen-Specific Immunotherapy

Asthma

Poland
Pyun BokYang
Merck Sharp & Dohme LLC

Completed

The Effectiveness of Montelukast on Atopic Dermatitis in Koreans

Atopic Dermatitis

Korea, Republic of
Ataturk University

Completed

Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations

Chronic Obstructive Pulmonary Disease

Turkey
Sara Varea

Completed

Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia

Coronavirus Infection

Spain, Argentina
University of Michigan
American Rhinologic Society

Completed

Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis

Chronic Sinusitis | Polyposis

United States
AstraZeneca

Completed

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo (CHASE 1)

Asthma

United States, Bulgaria, Hungary, Latvia, Poland, Slovakia, South Africa
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Montelukast in Bronchiolitis Obliterans Syndrome (MLK002)

Bronchiolitis Obliterans | Graft Rejection | Lung Transplantation

Belgium
Children's Mercy Hospital Kansas City
Merck Sharp & Dohme LLC

Completed

Montelukast in the Treatment of Duodenal Eosinophilia

Dyspepsia | Eosinophilic Gastroenteritis

United States
Shanghai Jiao Tong University School of Medicine
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Completed

Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma

Asthma

China
Bausch Health Americas, Inc.

Completed

Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)

Ulcerative Colitis

United States, Bulgaria, Canada, Czechia, Estonia, Hungary, Latvia, Lithuania, Poland, Russian Federation, Ukraine
Laval University
AstraZeneca

Completed

Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic Subjects (D5890L00013)

Asthma

Canada
Dr. Falk Pharma GmbH

Completed

9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease

Crohn´s Disease

Germany
University of Utah

Recruiting

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant (IMPACT)

Multiple Myeloma

United States
Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Enfermedades Respiratorias

Recruiting

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Radiation Pneumonitis

Mexico
ADMA Biologics, Inc.

Active, not recruiting

A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products

Primary Immune Deficiency Disorder

United States

3

Subscribe